Healthcare & Life Sciences
Flamingo Therapeutics
United Statesflamingotherapeutics.com
Flamingo Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
Activeseries-b
series-b
Stage
2018
Founded
1
Investors
About Flamingo Therapeutics
Based in the United States, Flamingo Therapeutics is a startup founded in 2018. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Flamingo Therapeutics is a clinical-stage biotechnology company developing small molecule and oligonucleotide therapies that target long non-coding RNAs (lncRNAs) to treat various cancers.
Explore Flamingo Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.